Clinical Trial Update: A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TOUR006 evaluating efficacy and safety in adults with Thyroid Eye Disease; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• TOUR006

Snippet

Sponsor: Tourmaline Bio, Inc. | Conditions: Thyroid Eye Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING